by Ruder Finn for Novartis Vaccines and Diagnostics Limited
by MHP Health Mandate for Bayer & the Advisory Group on Contraception
by MHP Health Mandate for Cancer Campaigning Group
by Atlantis Healthcare for AstraZeneca
by Publicis Life Brands Resolute for Janssen & EUROPSO
by Atlantis Healthcare for AstraZeneca
AstraZeneca and the Bristol Heart Institute’s Joint Working project, OneHeart, aims to improve self-management and adherence to prescribed therapies among Acute Coronary Syndromes (ACS) patients. 15 per cent of patients die within one year of their first ACS event1 and 46 per cent of patients prescribed oral antiplatelets (OAP) stop using them within 12 months, more than doubling their likelihood of death or a non-fatal heart attack.2
In launching a new OAP treatment, AstraZeneca looked to truly partner with the NHS by viewing medicines as an opportunity to deliver a pioneering, outcomes-focused solution. Utilising health psychology research, this personalised, multimedia programme targets complex, unhelpful beliefs shown to be predictors of non-adherence.
OneHeart’s success demonstrates a pharma/NHS collaboration driving improved health outcomes in line with NHS objectives such as medicines optimisation – and is generating roll-out to a further 20 acute trusts.
References:
1. Tang EW, Wong CK, Herbison P. Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. Am Heart J 2007;153:29-35.
2. Boggon R, van Staa TP, Timmis A, Hemingway H, Ray KK, Begg A, Emmas C, Fox KAA. (2011). Clopidogrel Discontinuation After Acute Coronary Syndromes: Frequency, Predictors and Associations with Death and Myocardial Infarctions
A clear, well explained programme that is highly relevant, ambitious and creative for the long-term benefit of patients. We saw good evidence of genuine partnership, robust insights, process and validation and good tangible results to date. What was very clear was that they really thought about how to make this a proper partnership with everyone having joint roles. A fantastic entry that promises more results to come in the longer term.
Entry deadline | 10th March 2023 |
Extended entry deadline | 17th March 2023 (additional fee applies) |
Judging days | 4th, 5th and 19th May 2023 |
Awards Ceremony | 6th July 2023 |
For sponsorship opportunities:
Sales Team
sales@pmlive.com
Tel: +44 (0)1372 414200
General event enquiries:
Debbie Tuesley
dtuesley@pmlive.com
Tel: +44 (0)1372 414243
Entry and dinner booking enquiries:
Charlotte Garnade
Email: cgarnade@pmlive.com
Tel: 01372 414253